Key result
Mini-thoracotomy AVR with rapid-deployment valves shows ~1% in-hospital mortality in a single-arm cohort.
Why the study?
Evidence for aortic valve replacement through right anterior thoracotomy using the Edwards Intuity Elite rapid-deployment bioprosthesis remains limited, with only three dedicated single-centre series published to date.
What are the perioperative safety outcomes, rhythm complication rates, and early haemodynamic performance of isolated aortic valve replacement via right anterior mini-thoracotomy using the Edwards Intuity Elite rapid-deployment bioprosthesis in a low-risk, single-centre cohort?
Observational (n=70)
No
What are the perioperative safety outcomes, rhythm complication rates, and early haemodynamic performance of isolated aortic valve replacement via right anterior mini-thoracotomy using the Edwards Intuity Elite rapid-deployment bioprosthesis in a low-risk, single-centre cohort?
Answers are grounded in this paper and cite their sources.
In a single-centre low-risk cohort of 70 patients, minimally invasive aortic valve replacement via right anterior thoracotomy with the Edwards Intuity Elite rapid-deployment valve was feasible with low postoperative gradients (median 8.0 mmHg) and no moderate/severe paravalvular leak, though accompanied by an 8.6% pacemaker rate, 91.3% transfusion rate, and one fatal femoral cannulation-site haemorrhage.
Background/objectives Evidence for aortic valve replacement through right anterior thoracotomy (RAT) using the Edwards Intuity Elite rapid-deployment bioprosthesis remains limited, with only three dedicated single-centre series published to date. We aimed to describe perioperative safety, early haemodynamic performance, permanent pacemaker implantation for third-degree atrioventricular block, and new-onset postoperative atrial fibrillation in a consecutive single-centre cohort. Analyses of factors associated with these two rhythm endpoints were exploratory in nature. Methods This is a retrospective, single-arm, single-centre observational series with no sternotomy, ministernotomy or sutured-valve comparator. We analysed 70 consecutive patients undergoing isolated aortic valve replacement via RAT with the Edwards Intuity Elite bioprosthesis at a single institution. Percutaneous femoral arterial and venous cannulation was used in all cases. Outcomes were described for the whole cohort. For exploratory event-versus-no-event comparisons, Mann–Whitney U and Fisher's exact tests were applied to permanent pacemaker implantation and new-onset atrial fibrillation; Spearman rank correlation and Mann–Whitney U tests explored associations with operative times and discharge pressure gradients. Because only 6 pacemaker and 7 atrial fibrillation events occurred, statistical power was limited. Results Median age was 71.0 years and median EuroSCORE II was 1.0%. Median cross-clamp time was 61.0 min (IQR 54–75) and median cardiopulmonary bypass time was 103.5 min (IQR 84–115). In-hospital mortality was 1.4% (one death from femoral cannulation-site haemorrhage; 95% CI 0.0%–7.7%), and no strokes occurred. Permanent pacemaker implantation was required in 6 patients (8.6%; 95% CI 3.2–17.7%) and new-onset atrial fibrillation occurred in 7 (10.0%; 95% CI 4.1–19.5%); age was significantly associated with pacemaker implantation (median 75.5 vs. 71.0 years, p = 0.038), while other exploratory comparisons were not significant. No moderate or severe paravalvular leak was observed. Median postoperative mean gradient was 8.0 mmHg (IQR 6–10) and median length of stay was 6.0 days (IQR 6.0–7.0). Packed red blood cell transfusion was required in 63 patients (91.3% of 69 evaluable; 95% CI 82.0–96.7%), and reoperation for bleeding in 3 (4.3%; 95% CI 0.9–12.0%). Exploratory analyses detected no statistically significant association with atrial fibrillation or operative times. Implanted valve size correlated weakly and inversely with postoperative mean gradient (Spearman rho = −0.26, p = 0.032). Conclusions In this descriptive, low-risk, single-centre cohort, RAT with a rapid-deployment bioprosthesis was feasible and was followed by low discharge gradients. The observed pacemaker, atrial fibrillation, transfusion, bleeding and access-site event rates are real-world descriptive estimates and do not constitute comparative evidence of benefit over other approaches or prostheses. The small number of events precludes conclusions about predictors. Larger prospective multicentre studies with comparator groups and systematic echocardiographic follow-up are required.
No takes yet. Share an insight, caveat, or question.
Jaworski et al. (2026) conducted an observational in Aortic valve disease (98.6% severe aortic stenosis, 1.4% aortic regurgitation) (n=70). Aortic valve replacement via right anterior mini-thoracotomy (RAT) with Edwards Intuity Elite rapid-deployment bioprosthesis was evaluated on In-hospital mortality (95% CI 0.0-7.7). Right anterior mini-thoracotomy AVR with the Edwards Intuity Elite valve resulted in 1.4% in-hospital mortality, 8.6% permanent pacemaker implantation, and 8.0 mmHg median mean gradient at discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: